Press releases

All Releases
View Summary Aastrom Announces Appointment of Zac Taylor as National Sales Director
Jul 14, 2014
PDF 11.3 KB Add to Briefcase
View Summary Aastrom Biosciences Added to Russell Microcap Index
Jun 30, 2014
PDF 11.7 KB Add to Briefcase
View Summary Aastrom Announces Initiation of Commercial Sales of Bone Marrow by Marrow Donation, LLC
Jun 24, 2014
PDF 11.0 KB Add to Briefcase
View Summary Aastrom Announces Strategic Plan for Recently Acquired Cell Therapy and Regenerative Medicine Business
Jun 16, 2014
PDF 17.8 KB Add to Briefcase
View Summary Aastrom Announces Investor Conference Call and Webcast June 16, 2014 at 8:30 AM EDT
Jun 15, 2014
PDF 12.1 KB Add to Briefcase
View Summary Aastrom Announces Appointment of Gerard Michel as Chief Financial Officer and Vice President, Corporate Development
Jun 4, 2014
PDF 11.1 KB Add to Briefcase
View Summary Aastrom Completes Acquisition of Sanofi's Cell Therapy and Regenerative Medicine Business
Jun 2, 2014
PDF 11.3 KB Add to Briefcase
View Summary Aastrom Biosciences Reports First-Quarter 2014 Financial Results
May 15, 2014
PDF 18.1 KB Add to Briefcase
View Summary Aastrom Biosciences to Host First Quarter 2014 Investor Call on May 15, 2014
May 9, 2014
PDF 12.8 KB Add to Briefcase
View Summary Aastrom to Hold Annual Meeting of Shareholders on May 7, 2014
May 2, 2014
PDF 11.0 KB Add to Briefcase
View Summary Aastrom Announces Definitive Agreement to Acquire Sanofi's Cell Therapy and Regenerative Medicine Business
Apr 21, 2014
PDF 12.4 KB Add to Briefcase
View Summary Aastrom Reports Data and Safety Monitoring Board Recommendation to Continue ixCELL-DCM Clinical Trial
Apr 9, 2014
PDF 11.2 KB Add to Briefcase
View Summary Aastrom Announces Appointments of Dr. Ross Tubo as Chief Scientific Officer and Dr. David Recker as Chief Medical Officer
Apr 1, 2014
PDF 12.0 KB Add to Briefcase
View Summary Aastrom Biosciences to Present at the 2014 Regen Med Investor Day
Mar 19, 2014
PDF 11.3 KB Add to Briefcase
View Summary Aastrom Biosciences Reports Fourth-Quarter and Year-End 2013 Financial Results
Mar 13, 2014
PDF 19.2 KB Add to Briefcase
View Summary Aastrom Biosciences to Host Fourth Quarter 2013 Investor Call on March 13, 2014
Mar 6, 2014
PDF 12.7 KB Add to Briefcase
View Summary Aastrom Biosciences Enters Into $15 Million Equity Commitment With Lincoln Park Capital
Jan 27, 2014
PDF 12.4 KB Add to Briefcase
View Summary Aastrom Biosciences Granted Composition-of-Matter Patent for Ixmyelocel-T in Australia
Dec 19, 2013
PDF 11.1 KB Add to Briefcase
View Summary Aastrom Biosciences Regains Compliance With NASDAQ Equity Standard Listing Requirement
Nov 15, 2013
PDF 10.7 KB Add to Briefcase
View Summary Aastrom Biosciences Reports Third-Quarter and Nine-Month 2013 Financial Results
Nov 12, 2013
PDF 19.5 KB Add to Briefcase
Showing 1-20 of 355 Page: 1 2 3 4 5 ... 18  Next 20
Add to Briefcase = add release to Briefcase
Stock Information
NASDAQ: ASTM
Price:
3.33
Change:
+ 0.05
Day High:
3.38
Day Low:
3.28
Volume:
66,300
4:00 PM ET on Jul 23, 2014
Delayed at least 20 minutes.
Provided by eSignal.

Shareholder Tools